Week 4: GLP-1 Progress After 30 Days By the end of the month, most patients experience GLP-1 before and after 1 month results, with a typical weight loss of 5-10 pounds
The escalation phase uses less peptide per week than the maintenance phase, so monthly costs increase as you progress through the schedule
With the obesity epidemic contributing to rising rates of diabetes, heart disease and other chronic conditions, GLP-1 therapies represent a potential turning point in the fight against these diseases
For example, Ozempic is approved for diabetes, and Wegovy is approved for weight loss, reducing cardiovascular disease risk, and treating certain patients with fatty liver disease
Thats why GLP-1 receptor agonists (like semaglutide and tirzepatide) were developedlonger-acting versions that extend these benefits